ロード中...

Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders

BACKGROUND: Clinical trials evaluating anti-CD20-mediated B-cell depletion in multiple sclerosis (MS) and neuromyelitis optica (NMO) generated encouraging results. Our recent studies in the MS model experimental autoimmune encephalomyelitis (EAE) attributed clinical benefit to extinction of activate...

詳細記述

保存先:
書誌詳細
主要な著者: Lehmann-Horn, Klaus, Schleich, Eva, Hertzenberg, Deetje, Hapfelmeier, Alexander, Kümpfel, Tania, von Bubnoff, Nikolas, Hohlfeld, Reinhard, Berthele, Achim, Hemmer, Bernhard, Weber, Martin S
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2011
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3214191/
https://ncbi.nlm.nih.gov/pubmed/22027448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-2094-8-146
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!